{"transactions":[{"id":308474,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-06-11T20:30:16.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":26.5,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted additional award of deferred shares under the Plan, which have not yet been delivered to the Director, and for which there has been a record date since June 10, 2025. Deferred shares will be delivered at the same time the shares subject to the applicable additional award are delivered, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted additional award of deferred shares under the Plan, which have not yet been delivered to the Director, and for which there has been a record date since June 10, 2025. Deferred shares will be delivered at the same time the shares subject to the applicable additional award are delivered, under and subject to the terms of the Plan."}],"balance_after":3152.62,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":26.5},"source":{"system":"sec-edgar","filing":"0001193125-26-267657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109198/000119312526267657/ownership.xml","form_type":"4"}},{"id":308473,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-06-11T20:30:16.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":636.87,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a grant date fair value of $105,000. Shares vest on the date immediately preceding the date of the Company's annual meeting of shareholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a grant date fair value of $105,000. Shares vest on the date immediately preceding the date of the Company's annual meeting of shareholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."}],"balance_after":3126.12,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":636.87},"source":{"system":"sec-edgar","filing":"0001193125-26-267657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109198/000119312526267657/ownership.xml","form_type":"4"}},{"id":308472,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-06-11T20:30:16.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":26.5,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a grant date fair value equal to the aggregate dividends on any previously granted annual award of deferred shares under the Plan for which there has been a record date since June 10, 2025. Deferred shares will be delivered at the same time the shares subject to the annual award are delivered, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a grant date fair value equal to the aggregate dividends on any previously granted annual award of deferred shares under the Plan for which there has been a record date since June 10, 2025. Deferred shares will be delivered at the same time the shares subject to the annual award are delivered, under and subject to the terms of the Plan."}],"balance_after":3152.62,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":26.5},"source":{"system":"sec-edgar","filing":"0001193125-26-267657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109198/000119312526267657/ownership.xml","form_type":"4"}},{"id":308471,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2026-06-11T20:30:16.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":636.87,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a grant date fair value of $105,000. Shares will be delivered following the Director's departure from the Board, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a grant date fair value of $105,000. Shares will be delivered following the Director's departure from the Board, under and subject to the terms of the Plan."}],"balance_after":3126.12,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":636.87},"source":{"system":"sec-edgar","filing":"0001193125-26-267657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109198/000119312526267657/ownership.xml","form_type":"4"}},{"id":312722,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-02-26T23:56:38.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1744,"price":485.11,"value":846031.84,"ownership":{"direct":true},"balance_after":47042,"source":{"system":"sec-edgar","filing":"0000875320-26-000122","document":"wk-form4_1772150196.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000122/wk-form4_1772150196.xml","form_type":"4"}},{"id":313127,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-02-19T21:30:13.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2294,"price":483.75,"value":1109722.5,"ownership":{"direct":true},"balance_after":48786,"source":{"system":"sec-edgar","filing":"0000875320-26-000100","document":"wk-form4_1771536607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000100/wk-form4_1771536607.xml","form_type":"4"}},{"id":313126,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-02-19T21:30:13.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":7365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on February 20, 2027."}],"balance_after":51080,"source":{"system":"sec-edgar","filing":"0000875320-26-000100","document":"wk-form4_1771536607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000100/wk-form4_1771536607.xml","form_type":"4"}},{"id":313470,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-02-18T21:47:35.000Z","date":"2026-02-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":4565,"price":487.76,"value":2226624.4,"ownership":{"direct":true},"balance_after":43715,"source":{"system":"sec-edgar","filing":"0000875320-26-000078","document":"wk-form4_1771451250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000078/wk-form4_1771451250.xml","form_type":"4"}},{"id":313857,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-02-12T22:10:28.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":3045,"price":468.41,"value":1426308.45,"ownership":{"direct":true},"balance_after":48280,"source":{"system":"sec-edgar","filing":"0000875320-26-000054","document":"wk-form4_1770934225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000054/wk-form4_1770934225.xml","form_type":"4"}},{"id":314823,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-01-26T21:38:20.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":4160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/12/2025 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest in installments beginning on 02/24/2026."}],"balance_after":51325,"source":{"system":"sec-edgar","filing":"0000875320-26-000028","document":"wk-form4_1769463497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000028/wk-form4_1769463497.xml","form_type":"4"}},{"id":314822,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-01-26T21:38:20.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":9440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 01/22/2026 and the shares will vest on 02/13/2026."}],"balance_after":47165,"source":{"system":"sec-edgar","filing":"0000875320-26-000028","document":"wk-form4_1769463497.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000028/wk-form4_1769463497.xml","form_type":"4"}},{"id":315363,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T21:04:39.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":9532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":189.38,"expiration_date":"2029-04-09","underlying":"Common Stock","underlying_shares":9532},"source":{"system":"sec-edgar","filing":"0000875320-26-000002","document":"wk-form4_1767906275.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000002/wk-form4_1767906275.xml","form_type":"4"}},{"id":315362,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-01-08T21:04:39.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":9532,"price":461,"value":4394252.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/09/2025."}],"balance_after":37725,"source":{"system":"sec-edgar","filing":"0000875320-26-000002","document":"wk-form4_1767906275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000002/wk-form4_1767906275.xml","form_type":"4"}},{"id":315361,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2026-01-08T21:04:39.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":9532,"price":189.38,"value":1805170.16,"ownership":{"direct":true},"balance_after":47257,"source":{"system":"sec-edgar","filing":"0000875320-26-000002","document":"wk-form4_1767906275.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000002/wk-form4_1767906275.xml","form_type":"4"}},{"id":316508,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2025-12-05T21:16:48.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":461,"value":3227000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/9/2025."}],"balance_after":37725,"source":{"system":"sec-edgar","filing":"0000875320-25-000247","document":"wk-form4_1764969405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000247/wk-form4_1764969405.xml","form_type":"4"}},{"id":316507,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CO & FO"}}],"security":"Common Stock","published_at":"2025-12-05T21:16:48.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":451,"value":3157000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 5/9/2025."}],"balance_after":44725,"source":{"system":"sec-edgar","filing":"0000875320-25-000247","document":"wk-form4_1764969405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000247/wk-form4_1764969405.xml","form_type":"4"}},{"id":321481,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-06-12T21:00:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":20.6,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted additional award of deferred shares under the Plan, which have not yet been delivered to the Director, and for which there has been a record date since June 4, 2024. Deferred shares will be delivered at the same time the shares subject to the applicable additional award\nare delivered, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted additional award of deferred shares under the Plan, which have not yet been delivered to the Director, and for which there has been a record date since June 4, 2024. Deferred shares will be delivered at the same time the shares subject to the applicable additional award\nare delivered, under and subject to the terms of the Plan."}],"balance_after":2489.25,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20.6},"source":{"system":"sec-edgar","filing":"0000950170-25-085537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017025085537/ownership.xml","form_type":"4"}},{"id":321480,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-06-12T21:00:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":793.4,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a grant date fair value of $100,000. Shares vest on the date immediately preceding the date of the Company's annual meeting of shareholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a grant date fair value of $100,000. Shares vest on the date immediately preceding the date of the Company's annual meeting of shareholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."}],"balance_after":2468.65,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":793.4},"source":{"system":"sec-edgar","filing":"0000950170-25-085537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017025085537/ownership.xml","form_type":"4"}},{"id":321479,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-06-12T21:00:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":20.6,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a grant date fair value equal to the aggregate dividends on any previously granted annual award of deferred shares under the Plan for which there has been a record date since June 4, 2024. Deferred shares will be delivered at the same time the shares subject to the annual award are delivered, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a grant date fair value equal to the aggregate dividends on any previously granted annual award of deferred shares under the Plan for which there has been a record date since June 4, 2024. Deferred shares will be delivered at the same time the shares subject to the annual award are delivered, under and subject to the terms of the Plan."}],"balance_after":2489.25,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":20.6},"source":{"system":"sec-edgar","filing":"0000950170-25-085537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017025085537/ownership.xml","form_type":"4"}},{"id":321478,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2025-06-12T21:00:10.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":793.4,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a grant date fair value of $100,000. Shares will be delivered following the Director's departure from the Board, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a grant date fair value of $100,000. Shares will be delivered following the Director's departure from the Board, under and subject to the terms of the Plan."}],"balance_after":2468.65,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":793.4},"source":{"system":"sec-edgar","filing":"0000950170-25-085537","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017025085537/ownership.xml","form_type":"4"}},{"id":324118,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-12T20:11:46.000Z","date":"2025-03-10","kind":"sale","planned":true,"acquired":false,"shares":3298,"price":500,"value":1649000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 8/8/2024."}],"balance_after":51671,"source":{"system":"sec-edgar","filing":"0000875320-25-000148","document":"wk-form4_1741810299.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000148/wk-form4_1741810299.xml","form_type":"4"}},{"id":325017,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-28T21:52:12.000Z","date":"2025-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":4962,"price":479.61,"value":2379824.82,"ownership":{"direct":true},"balance_after":54969,"source":{"system":"sec-edgar","filing":"0000875320-25-000137","document":"wk-form4_1740779526.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000137/wk-form4_1740779526.xml","form_type":"4"}},{"id":325173,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-26T21:16:47.000Z","date":"2025-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":3310,"price":483.28,"value":1599656.8,"ownership":{"direct":true},"balance_after":59931,"source":{"system":"sec-edgar","filing":"0000875320-25-000117","document":"wk-form4_1740604600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000117/wk-form4_1740604600.xml","form_type":"4"}},{"id":325778,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-19T21:38:37.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2293,"price":463.46,"value":1062713.78,"ownership":{"direct":true},"balance_after":63241,"source":{"system":"sec-edgar","filing":"0000875320-25-000097","document":"wk-form4_1740001110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000097/wk-form4_1740001110.xml","form_type":"4"}},{"id":326063,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-14T21:21:05.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":6655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock unit award that vests in installments beginning on 02/24/2026."}],"balance_after":65534,"source":{"system":"sec-edgar","filing":"0000875320-25-000075","document":"wk-form4_1739568057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000075/wk-form4_1739568057.xml","form_type":"4"}},{"id":326165,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-12T21:52:24.000Z","date":"2025-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2649,"price":467.98,"value":1239679.02,"ownership":{"direct":true},"balance_after":58879,"source":{"system":"sec-edgar","filing":"0000875320-25-000050","document":"wk-form4_1739397137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000050/wk-form4_1739397137.xml","form_type":"4"}},{"id":326531,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:45:05.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":7114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/07/2024 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest in installments beginning on 02/17/2025."}],"balance_after":61528,"source":{"system":"sec-edgar","filing":"0000875320-25-000026","document":"wk-form4_1738878299.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000026/wk-form4_1738878299.xml","form_type":"4"}},{"id":326530,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-06T21:45:05.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":10262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/04/2025 and the shares will vest on 02/26/2025."}],"balance_after":54414,"source":{"system":"sec-edgar","filing":"0000875320-25-000026","document":"wk-form4_1738878299.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532025000026/wk-form4_1738878299.xml","form_type":"4"}},{"id":329384,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-11-13T21:15:15.000Z","date":"2024-11-11","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":518.27,"value":1554810.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024."}],"balance_after":44137,"source":{"system":"sec-edgar","filing":"0000875320-24-000227","document":"wk-form4_1731532506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000227/wk-form4_1731532506.xml","form_type":"4"}},{"id":333017,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-06T21:58:22.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":9.35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted additional award of deferred shares under the Plan, which have not yet been delivered to the Director, and for which there has been a record date since June 6, 2023. Deferred shares will be delivered at the same time the shares subject to the applicable additional award are delivered, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted additional award of deferred shares under the Plan, which have not yet been delivered to the Director, and for which there has been a record date since June 6, 2023. Deferred shares will be delivered at the same time the shares subject to the applicable additional award are delivered, under and subject to the terms of the Plan."}],"balance_after":1675.25,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9.35},"source":{"system":"sec-edgar","filing":"0000950170-24-070021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017024070021/ownership.xml","form_type":"4"}},{"id":333016,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-06T21:58:22.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":944.55,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a value of $100,000. Shares vest on the date immediately preceding the date of the Company's annual meeting of shareholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a value of $100,000. Shares vest on the date immediately preceding the date of the Company's annual meeting of shareholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."}],"balance_after":1665.9,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":944.55},"source":{"system":"sec-edgar","filing":"0000950170-24-070021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017024070021/ownership.xml","form_type":"4"}},{"id":333015,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-06T21:58:22.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":9.35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted annual award of deferred shares under the Plan for which there has been a record date since June 6, 2023. Deferred shares will be delivered at the same time the shares subject to the annual award are delivered, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Constitutes an award of deferred shares under the Stock Incentive Plan having a value equal to the aggregate dividends on any previously granted annual award of deferred shares under the Plan for which there has been a record date since June 6, 2023. Deferred shares will be delivered at the same time the shares subject to the annual award are delivered, under and subject to the terms of the Plan."}],"balance_after":1675.25,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9.35},"source":{"system":"sec-edgar","filing":"0000950170-24-070021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017024070021/ownership.xml","form_type":"4"}},{"id":333014,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2024-06-06T21:58:22.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":944.55,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a value of $100,000. Shares will be delivered following the Director's departure from the Board, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a value of $100,000. Shares will be delivered following the Director's departure from the Board, under and subject to the terms of the Plan."}],"balance_after":1665.9,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":944.55},"source":{"system":"sec-edgar","filing":"0000950170-24-070021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109198/000095017024070021/ownership.xml","form_type":"4"}},{"id":333063,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-05T20:11:56.000Z","date":"2024-06-03","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":460,"value":1495000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 02/26/2024."}],"balance_after":47137,"source":{"system":"sec-edgar","filing":"0000875320-24-000170","document":"wk-form4_1717618308.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000170/wk-form4_1717618308.xml","form_type":"4"}},{"id":333278,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-05-30T20:07:52.000Z","date":"2024-05-28","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":454.79,"value":1478067.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 02/26/2024."}],"balance_after":50387,"source":{"system":"sec-edgar","filing":"0000875320-24-000162","document":"wk-form4_1717099663.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000162/wk-form4_1717099663.xml","form_type":"4"}},{"id":339117,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-27T22:08:27.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":3309,"price":431.79,"value":1428793.11,"ownership":{"direct":true},"balance_after":53583,"source":{"system":"sec-edgar","filing":"0000875320-24-000111","document":"wk-form4_1709071690.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000111/wk-form4_1709071690.xml","form_type":"4"}},{"id":339687,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-21T21:49:04.000Z","date":"2024-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2812,"price":420.58,"value":1182670.96,"ownership":{"direct":true},"balance_after":56892,"source":{"system":"sec-edgar","filing":"0000875320-24-000082","document":"wk-form4_1708552098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000082/wk-form4_1708552098.xml","form_type":"4"}},{"id":339686,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-21T21:49:04.000Z","date":"2024-02-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3750,"price":424.01,"value":1590037.5,"ownership":{"direct":true},"balance_after":59704,"source":{"system":"sec-edgar","filing":"0000875320-24-000082","document":"wk-form4_1708552098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000082/wk-form4_1708552098.xml","form_type":"4"}},{"id":340490,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-13T22:34:18.000Z","date":"2024-02-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":2607,"price":422.74,"value":1102083.18,"ownership":{"direct":true},"balance_after":63454,"source":{"system":"sec-edgar","filing":"0000875320-24-000057","document":"wk-form4_1707863641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000057/wk-form4_1707863641.xml","form_type":"4"}},{"id":341062,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-08T21:47:56.000Z","date":"2024-02-07","kind":"grant","planned":false,"acquired":true,"shares":7114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/17/2025."}],"balance_after":66061,"source":{"system":"sec-edgar","filing":"0000875320-24-000034","document":"wk-form4_1707428861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000034/wk-form4_1707428861.xml","form_type":"4"}},{"id":341061,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-08T21:47:56.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":9440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2023 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on  02/06/2024 and the shares will vest in installments beginning on 02/10/2024."}],"balance_after":58947,"source":{"system":"sec-edgar","filing":"0000875320-24-000034","document":"wk-form4_1707428861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000034/wk-form4_1707428861.xml","form_type":"4"}},{"id":341060,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-08T21:47:56.000Z","date":"2024-02-06","kind":"grant","planned":false,"acquired":true,"shares":5814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation\ncommittee certified as to the level of performance-goal attainment on 02/06/2024 and the shares will vest on 02/20/2024."}],"balance_after":49507,"source":{"system":"sec-edgar","filing":"0000875320-24-000034","document":"wk-form4_1707428861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000034/wk-form4_1707428861.xml","form_type":"4"}},{"id":342835,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:17:23.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":405,"value":1215000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/18/2023."}],"balance_after":43693,"source":{"system":"sec-edgar","filing":"0000875320-24-000002","document":"wk-form4_1704403018.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532024000002/wk-form4_1704403018.xml","form_type":"4"}},{"id":344247,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-11-21T21:07:18.000Z","date":"2023-11-20","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":349.88,"value":1049640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/18/2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $349.88 (range $349.76 to $350.00)."}],"balance_after":46693,"source":{"system":"sec-edgar","filing":"0000875320-23-000043","document":"wk-form4_1700600822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532023000043/wk-form4_1700600822.xml","form_type":"4"}},{"id":345673,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-09-22T21:00:12.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":721.35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a value of $92,500, prorated for the number of days between the Director's election to the Board and the expected date of the next annual meeting of stockholders. Shares vest on the date immediately preceding the date of the Company's annual meeting of stockholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Constitutes an additional award of deferred shares under the Stock Incentive Plan having a value of $92,500, prorated for the number of days between the Director's election to the Board and the expected date of the next annual meeting of stockholders. Shares vest on the date immediately preceding the date of the Company's annual meeting of stockholders next succeeding the award grant date, provided that the recipient is still a Director on that date or, to the extent provided by the terms of the award document, in connection with an earlier Change of Control. Vested shares will be delivered following vesting or following the Director's departure from the Board, in accordance with the Director's advance irrevocable election, if any, under and subject to the terms of the Plan."}],"balance_after":721.35,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":721.35},"source":{"system":"sec-edgar","filing":"0001209191-23-050394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109198/000120919123050394/doc4.xml","form_type":"4"}},{"id":345672,"issuer":{"id":2870,"kind":"organization","name":"TJX COMPANIES INC /DE/","symbol":"TJX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Stock Units","published_at":"2023-09-22T21:00:12.000Z","date":"2023-09-20","kind":"grant","planned":false,"acquired":true,"shares":721.35,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a value of $92,500, prorated for the number of days between the Director's election to the Board and the expected date of the next annual meeting of stockholders. Shares will be delivered following the\nDirector's departure from the Board, under and subject to the terms of the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Constitutes an annual award of deferred shares under the Stock Incentive Plan having a value of $92,500, prorated for the number of days between the Director's election to the Board and the expected date of the next annual meeting of stockholders. Shares will be delivered following the\nDirector's departure from the Board, under and subject to the terms of the Plan."}],"balance_after":721.35,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":721.35},"source":{"system":"sec-edgar","filing":"0001209191-23-050394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109198/000120919123050394/doc4.xml","form_type":"4"}},{"id":350766,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-28T20:13:21.000Z","date":"2023-03-24","kind":"sale","planned":true,"acquired":false,"shares":1768,"price":305.38,"value":539911.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2022."}],"balance_after":49611,"source":{"system":"sec-edgar","filing":"0001209191-23-021394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123021394/doc4.xml","form_type":"4"}},{"id":350945,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T20:21:13.000Z","date":"2023-03-17","kind":"sale","planned":true,"acquired":false,"shares":16,"price":301.13,"value":4818.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022."}],"balance_after":51379,"source":{"system":"sec-edgar","filing":"0001209191-23-020244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123020244/doc4.xml","form_type":"4"}},{"id":350944,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T20:21:13.000Z","date":"2023-03-17","kind":"sale","planned":true,"acquired":false,"shares":240,"price":299.58,"value":71899.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $299.58 (range $299.09 to $300.06)."}],"balance_after":51395,"source":{"system":"sec-edgar","filing":"0001209191-23-020244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123020244/doc4.xml","form_type":"4"}},{"id":350943,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T20:21:13.000Z","date":"2023-03-17","kind":"sale","planned":true,"acquired":false,"shares":360,"price":298.09,"value":107312.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $298.09 (range $297.65 to $298.48)."}],"balance_after":51635,"source":{"system":"sec-edgar","filing":"0001209191-23-020244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123020244/doc4.xml","form_type":"4"}},{"id":350942,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T20:21:13.000Z","date":"2023-03-17","kind":"sale","planned":true,"acquired":false,"shares":240,"price":296.3,"value":71112.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $296.30 (range $296.14 to $296.45)."}],"balance_after":51995,"source":{"system":"sec-edgar","filing":"0001209191-23-020244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123020244/doc4.xml","form_type":"4"}},{"id":350941,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T20:21:13.000Z","date":"2023-03-17","kind":"sale","planned":true,"acquired":false,"shares":784,"price":295.43,"value":231617.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $295.43 (range $295.09 to $295.97)."}],"balance_after":52235,"source":{"system":"sec-edgar","filing":"0001209191-23-020244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123020244/doc4.xml","form_type":"4"}},{"id":350940,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-21T20:21:13.000Z","date":"2023-03-17","kind":"sale","planned":true,"acquired":false,"shares":360,"price":294.52,"value":106027.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1, which was adopted on 08/08/2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $294.52 (range $293.98 to $294.81)."}],"balance_after":53019,"source":{"system":"sec-edgar","filing":"0001209191-23-020244","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123020244/doc4.xml","form_type":"4"}},{"id":351243,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":62,"price":296.77,"value":18399.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."}],"balance_after":53379,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351242,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":292,"price":295.89,"value":86399.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Open market sales reported on this line occurred at a weighted average price of $295.89 (range $295.33 to $296.32)."}],"balance_after":53441,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351241,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":715,"price":294.52,"value":210581.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Open market sales reported on this line occurred at a weighted average price of $294.52 (range $294.13 to $294.81)."}],"balance_after":53733,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351240,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":1153,"price":293.35,"value":338232.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Open market sales reported on this line occurred at a weighted average price of $293.35 (range $292.99 to $293.80)."}],"balance_after":54448,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351239,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":420,"price":292.41,"value":122812.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Open market sales reported on this line occurred at a weighted average price of $292.41 (range $291.97 to $292.82)."}],"balance_after":55061,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351238,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-13","kind":"sale","acquired":false,"shares":24,"price":288.31,"value":6919.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."}],"balance_after":56021,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351237,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":102,"price":294.94,"value":30083.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $294.94 (range $294.85 to $295.35)."}],"balance_after":56045,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351236,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":27,"price":293.61,"value":7927.47,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."}],"balance_after":56147,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351235,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":185,"price":292.68,"value":54145.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $292.68 (range $292.14 to $293.12)."}],"balance_after":56174,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351234,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":541,"price":291.47,"value":157685.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $291.47 (range $291.10 to $292.00)."}],"balance_after":56359,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351233,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":30,"price":289.44,"value":8683.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."}],"balance_after":56900,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351232,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":327,"price":288.91,"value":94473.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $288.91 (range $288.37 to $289.34)."}],"balance_after":56930,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351231,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":515,"price":287.83,"value":148232.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $287.83 (range $287.30 to $288.20)."}],"balance_after":57257,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":351230,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-14T20:22:50.000Z","date":"2023-03-10","kind":"sale","acquired":false,"shares":361,"price":286.64,"value":103477.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $286.64 (range $286.17 to $287.16)."}],"balance_after":57772,"source":{"system":"sec-edgar","filing":"0001209191-23-018460","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123018460/doc4.xml","form_type":"4"}},{"id":352321,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:14:19.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":3308,"price":289.12,"value":956408.96,"ownership":{"direct":true},"balance_after":58133,"source":{"system":"sec-edgar","filing":"0001209191-23-013774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123013774/doc4.xml","form_type":"4"}},{"id":352883,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-22T21:50:23.000Z","date":"2023-02-17","kind":"tax_withholding","acquired":false,"shares":3750,"price":292.85,"value":1098187.5,"ownership":{"direct":true},"balance_after":61441,"source":{"system":"sec-edgar","filing":"0001209191-23-011707","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123011707/doc4.xml","form_type":"4"}},{"id":353506,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:15:02.000Z","date":"2023-02-13","kind":"tax_withholding","acquired":false,"shares":4992,"price":298.26,"value":1488913.92,"ownership":{"direct":true},"balance_after":65191,"source":{"system":"sec-edgar","filing":"0001209191-23-009243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123009243/doc4.xml","form_type":"4"}},{"id":353505,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T22:15:02.000Z","date":"2023-02-10","kind":"tax_withholding","acquired":false,"shares":2707,"price":294.33,"value":796751.31,"ownership":{"direct":true},"balance_after":70183,"source":{"system":"sec-edgar","filing":"0001209191-23-009243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123009243/doc4.xml","form_type":"4"}},{"id":354138,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T22:03:52.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":9440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/10/2024."}],"balance_after":72890,"source":{"system":"sec-edgar","filing":"0001209191-23-007012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123007012/doc4.xml","form_type":"4"}},{"id":354137,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T22:03:52.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/01/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest in installments beginning on 02/24/2023."}],"balance_after":63450,"source":{"system":"sec-edgar","filing":"0001209191-23-007012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123007012/doc4.xml","form_type":"4"}},{"id":354136,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-03T22:03:52.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/05/2020 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2023 and the shares will vest on 02/13/2023."}],"balance_after":53188,"source":{"system":"sec-edgar","filing":"0001209191-23-007012","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919123007012/doc4.xml","form_type":"4"}},{"id":361920,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:07:22.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":3,"price":264.37,"value":793.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."}],"balance_after":42730,"source":{"system":"sec-edgar","filing":"0000899243-22-016635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016635/doc4.xml","form_type":"4"}},{"id":361919,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:07:22.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":32,"price":262.06,"value":8385.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $262.06 (range $261.89 to $262.23)."}],"balance_after":42733,"source":{"system":"sec-edgar","filing":"0000899243-22-016635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016635/doc4.xml","form_type":"4"}},{"id":361918,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:07:22.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":48,"price":261.15,"value":12535.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $261.15 (range $260.79 to $261.63)."}],"balance_after":42765,"source":{"system":"sec-edgar","filing":"0000899243-22-016635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016635/doc4.xml","form_type":"4"}},{"id":361917,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:07:22.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":80,"price":259.45,"value":20756.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $259.45 (range $258.98 to $259.90)."}],"balance_after":42813,"source":{"system":"sec-edgar","filing":"0000899243-22-016635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016635/doc4.xml","form_type":"4"}},{"id":361916,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:07:22.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":60,"price":258.21,"value":15492.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $258.21 (range $257.98 to $258.61)."}],"balance_after":42893,"source":{"system":"sec-edgar","filing":"0000899243-22-016635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016635/doc4.xml","form_type":"4"}},{"id":361915,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:07:22.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":100,"price":257.18,"value":25718.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $257.18 (range $256.68 to $257.47)."}],"balance_after":42953,"source":{"system":"sec-edgar","filing":"0000899243-22-016635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016635/doc4.xml","form_type":"4"}},{"id":361914,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T21:07:22.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":20,"price":254.87,"value":5097.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."}],"balance_after":43053,"source":{"system":"sec-edgar","filing":"0000899243-22-016635","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016635/doc4.xml","form_type":"4"}},{"id":362002,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-03T20:27:03.000Z","date":"2022-04-29","kind":"tax_withholding","acquired":false,"shares":547,"price":276.17,"value":151064.99,"ownership":{"direct":true},"balance_after":43073,"source":{"system":"sec-edgar","filing":"0000899243-22-016318","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016318/doc4.xml","form_type":"4"}},{"id":363065,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:06:05.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":223,"price":266.68,"value":59469.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $266.68 (range $266.55 to $266.83)."}],"balance_after":43620,"source":{"system":"sec-edgar","filing":"0000899243-22-013708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013708/doc4.xml","form_type":"4"}},{"id":363064,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:06:05.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":536,"price":265.95,"value":142549.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $265.95 (range $265.55 to $266.47)."}],"balance_after":43843,"source":{"system":"sec-edgar","filing":"0000899243-22-013708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013708/doc4.xml","form_type":"4"}},{"id":363063,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:06:05.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":1142,"price":265.06,"value":302698.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $265.06 (range $264.53 to $265.48)."}],"balance_after":44379,"source":{"system":"sec-edgar","filing":"0000899243-22-013708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013708/doc4.xml","form_type":"4"}},{"id":363062,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:06:05.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":381,"price":263.67,"value":100458.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $263.67 (range $263.45 to $264.42)."}],"balance_after":45521,"source":{"system":"sec-edgar","filing":"0000899243-22-013708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013708/doc4.xml","form_type":"4"}},{"id":363061,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:06:05.000Z","date":"2022-04-01","kind":"sale","acquired":false,"shares":300,"price":261.42,"value":78426.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $261.42 (range $261.04 to $261.80)."}],"balance_after":45902,"source":{"system":"sec-edgar","filing":"0000899243-22-013708","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322013708/doc4.xml","form_type":"4"}},{"id":363614,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-21T20:12:41.000Z","date":"2022-03-17","kind":"sale","acquired":false,"shares":61,"price":251.05,"value":15314.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."}],"balance_after":46202,"source":{"system":"sec-edgar","filing":"0000899243-22-011703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322011703/doc4.xml","form_type":"4"}},{"id":363613,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-21T20:12:41.000Z","date":"2022-03-17","kind":"sale","acquired":false,"shares":3110,"price":250.13,"value":777904.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $250.13 (range $250.00 to $250.61)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":46263,"source":{"system":"sec-edgar","filing":"0000899243-22-011703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322011703/doc4.xml","form_type":"4"}},{"id":365002,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-28T22:29:41.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":2189,"price":227.86,"value":498785.54,"ownership":{"direct":true},"balance_after":49373,"source":{"system":"sec-edgar","filing":"0000899243-22-008128","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322008128/doc4.xml","form_type":"4"}},{"id":365559,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-22T22:04:43.000Z","date":"2022-02-17","kind":"tax_withholding","acquired":false,"shares":3439,"price":232.51,"value":799601.89,"ownership":{"direct":true},"balance_after":51562,"source":{"system":"sec-edgar","filing":"0000899243-22-007217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322007217/doc4.xml","form_type":"4"}},{"id":366078,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-14T21:24:03.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":2434,"price":237.74,"value":578659.16,"ownership":{"direct":true},"balance_after":55001,"source":{"system":"sec-edgar","filing":"0001209191-22-009252","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122009252/doc4.xml","form_type":"4"}},{"id":366648,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:29:28.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":2944,"price":250.07,"value":736206.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Transaction made pursuant to Mr. Wagner's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $250.07 (range $250.00 to $250.09)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Mr. Wagner undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":57435,"source":{"system":"sec-edgar","filing":"0001209191-22-006796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006796/doc4.xml","form_type":"4"}},{"id":366647,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:29:28.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":10262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/24/2023."}],"balance_after":60379,"source":{"system":"sec-edgar","filing":"0001209191-22-006796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006796/doc4.xml","form_type":"4"}},{"id":366646,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:29:28.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":11628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest in installments beginning on 02/17/2022."}],"balance_after":50117,"source":{"system":"sec-edgar","filing":"0001209191-22-006796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006796/doc4.xml","form_type":"4"}},{"id":366645,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T21:29:28.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":3698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 04/10/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest on 02/24/2022."}],"balance_after":38489,"source":{"system":"sec-edgar","filing":"0001209191-22-006796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006796/doc4.xml","form_type":"4"}},{"id":375972,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-06T01:26:09.000Z","date":"2021-04-30","kind":"tax_withholding","acquired":false,"shares":547,"price":217.21,"value":118813.87,"ownership":{"direct":true},"balance_after":34679,"source":{"system":"sec-edgar","filing":"0001209191-21-030524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121030524/doc4.xml","form_type":"4"}},{"id":379365,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-26T21:29:11.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":547,"price":217.57,"value":119010.79,"ownership":{"direct":true},"balance_after":35226,"source":{"system":"sec-edgar","filing":"0001209191-21-014759","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121014759/doc4.xml","form_type":"4"}},{"id":380483,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-12T21:19:14.000Z","date":"2021-02-10","kind":"tax_withholding","acquired":false,"shares":2365,"price":214.16,"value":506488.4,"ownership":{"direct":true},"balance_after":35773,"source":{"system":"sec-edgar","filing":"0001209191-21-010133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121010133/doc4.xml","form_type":"4"}},{"id":380776,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14560,"kind":"person","name":"WAGNER CHARLES F JR","position":1,"cik":"0001223348","reported_name":"WAGNER CHARLES F JR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-05T22:00:43.000Z","date":"2021-02-03","kind":"grant","acquired":true,"shares":11627,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock unit award that vests in installments beginning on 02/17/2022."}],"balance_after":38138,"source":{"system":"sec-edgar","filing":"0001209191-21-008168","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121008168/doc4.xml","form_type":"4"}}],"next_cursor":"2021-02-05T22:00:43.000000Z,380776"}